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Abstract
Background: Behcet’s disease (BD)-related aortic regurgitation (AR) is known to be associated with paravalvular
leakage (PVL) after successful aortic valve (AV) surgery. This study aimed to determine predictors of PVL after
successful AV surgery in BD patients. We retrospectively collected data of 35 patients (42.1 ± 9.1 years, 27 men)
who underwent surgery for severe BD-related AR at two tertiary centers. The diagnosis was established based on
echocardiographic, surgical, and/or pathological findings in conjunction with the International Study Group criteria
for BD. A total of 76 cases of AV surgery in 35 patients were analyzed.
Results: A median follow-up duration was 8.0 years (interquartile range, 5.4–14.3 years). PVL developed in 18
patients (51.4%) within 2 years after the first surgery. Six patients who met the diagnostic criteria for BD
did not develop PVL, in whom 5 patients took immunosuppressive therapy (IST). However, 4 of 9 patients
(44.4%) who did not meet the diagnostic criteria developed PVL, in whom four (44.4%) patients took IST.
On multivariable analysis, postoperative IST and concomitant aortic root replacement (ARR) were two
independent predictors for less PVL development (HR 0.38, 95% CI 0.17–0.89, p = 0.025 for postoperative IST;
HR 0.17, 95% CI 0.08–0.36, p < 0.001 for concomitant ARR). Preoperative IST use did not determine PVL
development (p = 0.75).
Conclusions: Postoperative, but not preoperative, IST and concomitant ARR were independent predictors of
less development of PVL. Special attention is required for early diagnosis BD-related AR, especially in patients
not satisfying the current diagnostic criteria.
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Background
Behcet’s disease (BD) is a chronic systemic inflam-
matory disorder of unknown etiology, characterized
by recurrent orogenital ulcers and other organ in-
volvement such as skin and eyes. Cardiac involve-
ment in BD is uncommon but is associated with
life-threatening complications [1–6]. Among various
manifestations of cardiac BD, aortic regurgitation
(AR) is the most serious complication, because early
diagnosis and surgical treatment are challenging [3,
4]. The fragility of aortic structures and tissue in-
flammation in BD make surgical treatment of AR
more difficult, frequently resulting in paravalvular
leakage (PVL), pseudoaneurysm formation, and even
death [3–5, 7–9]. Prognosticators have been sug-
gested, however, the number of patients included in
earlier studies was too small to draw robust conclu-
sions. This study aimed to determine the predictors
of PVL after corrective aortic valve (AV) surgery for
BD-related AR at two large tertiary university
hospitals.
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We meticulously reviewed medical records of 636 pa-
tients who underwent corrective AV surgery for severe
AR at two tertiary centers (354 patients at Seoul Na-
tional University Hospital [SNUH] from 2008 to 2016,
and 282 patients at Samsung Medical Center [SMC]
from 1995 to 2016) and selected BD-related AR patients
(Additional file 1: Figure S1). AV surgeries included AV
repair, AV replacement (AVR), and composite graft re-
placement of the AV, aortic root, and ascending aorta
(i.e., Bentall procedure).
Diagnosis of BD-related AR was preoperatively and/or
postoperatively established based on clinical, echocardio-
graphic features, and pathology of surgical specimens.
Characteristic echocardiographic features of AV involve-
ment in BD included 1) aneurysmal change of AV cusp,
2) pseudoaneurysm of aortic root or ascending aorta,
and 3) dissection of the interventricular septum, as pre-
viously suggested (Fig. 1, Additional file 2: Video S1,
Additional file 3: Video S2, Additional file 4:Video S3)
[3–5, 8, 10]. Aneurysmal change of AV cusp is defined
as a primary ectatic change of AV cusp with redundant
motion, resulting in AV malcoaptation with severe AR.
Because it was reported that BD patients with severe
AR or other vascular involvement do not fully meet the
ISG criteria in many cases [3, 4, 8, 11–13], 35 patients
were categorized based on the International Study
Group (ISG) criteria [14] to evaluate the sensitivity of
the conventional diagnostic criteria for BD in patients
with BD-related severe AR. “Definite BD” was defined if
a patient showed recurrent oral ulcers and at least two
of the following features; recurrent genital ulcers, ocular
lesions, skin lesions, and a positive pathergy test result.
“Suspected BD” was defined if a patient showed recur-
rent oral aphthous ulcers plus one additional organ in-
volvement. Patients with recurrent oral ulcer only and
those who did not meet any diagnostic criterion were
classified separately. To confirm the diagnosis in these
patients, great effort was particularly made to reach a
consensus on the diagnosis of BD among cardiologists,
rheumatologists, cardiac pathologists, and cardiac sur-
geons. In addition, for patients who previously under-
went AV surgery elsewhere, external echocardiographic
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Fig. 1 Representative case of Behcet’s disease-related aortic regurgitation. A 36-year-old male presented with Behcet’s disease-related severe
aortic regurgitation. Pseudoaneurysm (asterisk) and interventricular septal dissection (arrow) between the right and left coronary cusps were
clearly shown on transesophageal echocardiography (a, b), in the surgical field (c) and on computed tomography (d-f). R, right coronary cusp; L,
left coronary cusp; N, non-coronary cusp; LCA, left coronary artery; RCA, right coronary artery
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images, medical records at the time of the first AV sur-
gery including surgical records and pathological findings
were thoroughly reviewed. Patients with features sug-
gesting infective endocarditis such as vegetation, positive
blood cultures at the first surgery, and positive Gram
staining in the surgical specimen were systematically
excluded.
Using the above criteria, we found 20 patients with
BD-related AR, with an overall prevalence rate of 3.1%
(20/636, 2.8% in SNUH and 3.5% in SMC) among the
patients who underwent AV surgery due to severe AR.
On top of that, we also collected follow-up data of 15
patients with BD-related AR that were previously pub-
lished elsewhere [4]. Therefore, a total of 35 patients
with severe BD-related AR were finally analyzed in this
report (Additional file 1: Figure S1). This study was ap-
proved by the institutional review board of each hospital.
The need for informed consent was waived owing to the
retrospective nature of this study.
Patient management
The type of surgery performed was determined at the
discretion of the attending cardiac surgeons. Surgical
method used was previously described in detail [5]. Pre-
or postoperative immunosuppressive therapy (IST) was
mainly guided by rheumatologists. Although standard
IST regimen for BD-related AR has not been established
yet [15], intravenous corticosteroid was a medication of
choice prescribed before surgery, and low dose of oral
corticosteroid with/without azathioprine was prescribed
after surgery in most patients.
Data procurement
Clinical records of all patients undergoing AV surgery, in-
cluding medical charts and preoperative echocardio-
graphic findings, were retrospectively reviewed. Surgical
findings, pathological findings for the surgical specimen,
and follow-up data on PVL development, additional surgi-
cal procedure, pacemaker implantation for complete atrio-
ventricular block (CAVB), and death were also obtained.
According to earlier studies on BD-related AR [4], most
BD-related PVL after index surgery was observed within
2 years after surgery. Thus, PVL detected within 2 years
after each surgery was considered BD-related PVL.
Statistical analysis
Categorical variables were expressed as numbers (per-
centages), and continuous variables as median with
interquartile range or mean ± standard deviation, as ap-
propriate. We used Cox proportional hazards model to
find factors predicting BD-related PVL, and the hazard
ratio (HR) was adjusted for clinical risk factors showing
significant associations (p < 0.1) with outcomes in the
univariate analysis. The final model was further adjusted
for intra-cluster correlation because some patients
underwent multiple AV surgeries for recurrent PVL.
Kaplan-Meier curves were generated to estimate the sur-
vival function of time-to-events according to surgical
technique and IST use. Differences in the curves were
compared using the log-rank test. A two-sided p value <
0.05 was considered statistically significant. All statistical
analyses were conducted using R software version 3.4.2.
Results
Baseline characteristics and diagnosis of BD
The baseline characteristics of the 35 patients are sum-
marized in Table 1. BD was diagnosed according to the
ISG criteria prior to the first surgery and was well under
control by IST in four patients (11.4%). In nine patients
(25.7%), the ISG criteria was not met prior to the first
surgery, but echocardiographic and surgical findings
were highly suggestive of BD. The remaining 22 patients
(62.9%) were finally diagnosed with severe BD-related
Table 1 Baseline characteristics and outcomes
All patients (N = 35)
Baseline
Age at the 1st surgery (years) 42.1 ± 9.1 (23, 60)
Male, n (%) 27 (77.1%)
ESR (mm/hr) 31.9 ± 36.8
CRP (mg/dL) 1.1 ± 1.8
Clinical manifestations of BD
Recurrent oral ulcer 32 (91.4%)
Genital ulcer 9 (25.7%)
Eye involvement 1 (2.9%)
Skin lesion 21 (60.0%)
Positive Pathergy test 2 (5.7%)
Fulfillment of ISG criteria
Definite 6 (17.1%)
Suspected 20 (57.1%)




Cardiac death 11 (31.4%)
Heart transplantation 1 (2.9%)
Complete atrioventricular block 17 (48.6%)
Number of open heart surgeries 2.4 ± 1.1
More than 2 open heart surgeries 28 (80.0%)
AV paravalvular leakage within 2 years 18 (51.4%)
Values are mean ± SD (minimum value, maximum value) or n (%)
ESR erythrocyte sediment rate, CRP C-reactive protein, BD Behcet’s disease, ISG
International study group, AV aortic valve
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AR after prosthetic valve failure developed, given the
surgical and pathological findings.
Throughout the disease course, BD could be con-
firmed in six (17.1%) patients based on the ISG criteria,
including four patients already diagnosed with BD prior
to the first surgery (definite BD group). Twenty (57.1%)
patients were classified into the suspected BD group. Six
patients (17.1%) complained of recurrent oral ulcers
only, and the remaining three (8.6%) did not meet any
component of the ISG criteria. On the other hand, 26
(74.3%) of 35 patients could be diagnosed with BD based
on the International Criteria for Behcet’s Disease (ICBD)
criteria [16].
More than half of patients (19 [57.1%]) initially com-
plained of exertional dyspnea and/or orthopnea, with
consequent development of chest pain and palpitation (6
[17.1%] for both symptoms). Syncope and low-grade
fever were the presenting symptoms in four (11.4%) and
one (2.9%), respectively. Blood cultures were negative in
all 35 patients. Only 2 patients had an ascending aorta
diameter more than 45 mm on the initial computed
tomographic angiography or echocardiography, in both
of whom aortic root replacement (ARR) was performed
along with AV replacement. Other vascular involvement
was not found in any patient.
Long-term outcomes and PVL development (Table 1,
Fig. 2)
All patients were followed up until June 2017, with a
median follow-up duration of 8.0 years (minimum
255 days, maximum 23.9 years; interquartile range,
5.4–14.3 years). Sixteen patients (45.7%) died, and one
(2.9%) underwent heart transplantation. Causes of
non-cardiac death were cancer progression (n = 2),
uncontrolled colitis (n = 1), stroke (n = 1), and un-
known (n = 1). Cardiac death occurred in 11 patients
(31.4%), of whom, three died of immediate postopera-
tive complications (two, prosthetic valve endocarditis;
three, in-hospital cardiac arrest; one, heart failure pro-
gression), and two, sudden death outside the hospital.
Of the three patients who died of cardiac arrest in
the hospital, two died preoperatively during admission
for PVL surgery, and one during admission for pace-
maker implantation for CAVB (Fig. 2).
PVL at the prosthetic AV developed in 18 patients
(51.4%) within 2 years after the first surgery for severe
Fig. 2 Summary of clinical outcomes of 35 patients with Behcet’s disease-related aortic regurgitation. Of the 35 patients who underwent aortic
valve (AV) surgery, 18 developed paravalvular leakage (PVL) within 2 years after surgery. One patient died, and 7 patients survived without PVL.
Along with 9 patients who had PVL at 2 years after surgery, 27 patients underwent the second surgery for PVL. Two patients died before the third
surgery, and 7 developed PVL within 2 years. Of the 12 patients who underwent the third surgery, 4 developed PVL within 2 years after surgery
and 2 developed PVL 2 years after surgery. Three patients died before the fourth surgery and 3 patients underwent the fourth surgery. One
patient died, and 1 survived without PVL, and 1 developed PVL after 2 years but survived without surgery. A total of 76 AV surgeries were
performed, and 29 PVLs developed within 2 years after AV surgery. * Including one heart transplantation. † The patient has survived with medical
treatment 10 years after the fourth surgery
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AR. All six patients who met the ISG criteria (i.e., defin-
ite BD group) did not experience PVL, in whom 5 pa-
tients took IST. In contrast, PVL developed in 14 of 20
patients (70%) of the suspected BD group in whom only
two (10%) took IST, and PVL developed in 4 of 9 pa-
tients (44.4%) who did not meet the ISG criteria in
whom four (44.4%) patients took IST. In summary, none
of the patients in the definite BD group developed PVL,
whereas a substantial number of patients who were not
included in the definite BD group had PVL (Additional
file 1: Figure S2).
As shown in Fig. 3, interestingly, the number of open
heart surgeries (OHS) per patient, all-cause mortality,
cardiac mortality, and the incidence of PVL at the pros-
thetic AV tended to decrease after the clinical applica-
tion of characteristic echocardiographic findings [3–5, 8]
to diagnose severe BD-related AR.
Overall, 83 OHSs were performed (mean, 2.4 ± 1.1;
minimum 1, maximum 5) during follow-up; 76, AV sur-
geries; 3, pseudoaneurysm repairs; 3, isolated mitral
valve replacements; and 1, heart transplantation. Of
note, 28 patients (80%) underwent OHSs more than two
times. We could not conclude that the three isolated mi-
tral valve replacements were related to BD, based on the
available data; however, BD might be a plausible cause of
at least two surgeries, because PVL was the major patho-
logical finding.
Predictors of PVL in 76 AV surgeries
A total of 76 AV surgeries were analyzed to estimate the
risk of PVL for each AV surgery. PVL at the prosthetic
AV developed after 29 AV surgeries. Univariate Cox pro-
portional hazards analysis showed that female sex, pre-
operative and postoperative ISTs, and concomitant ARR
























































Fig. 3 Temporal trends of outcomes according to the year of the first surgery. With time, there was a decreasing trend in (a) mean number of
open heart surgeries (OHS) per patient, (b) paravalvular leakage (PVL) development, (c) all-cause mortality, and (d) cardiac mortality. Please note
that clinical outcome has markedly improved since 2008, when unique echocardiographic findings suggesting severe Behcet’s disease-related
aortic regurgitation were clinically introduced
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were associated with less PVL development. Notably,
preoperative erythrocyte sedimentation rate was not a
predictor of PVL in the univariate analysis. In the multi-
variate analysis, concomitant ARR and use of postopera-
tive IST were two independent predictors of less PVL
development (HR 0.17, 95% CI 0.08–0.36, p < 0.001 for
concomitant ARR; HR 0.38, 95% CI 0.17–0.89 p = 0.025
for postoperative IST) (Table 2). We also performed sen-
sitivity analysis to confirm the role of preoperative IST
in the prevention of PVL development, because all but
one patient undergoing preoperative IST took postoper-
ative IST. Of 76 AV surgeries, postoperative IST was
used in 43 cases, among which preoperative IST was
conducted in 32 cases (74.4%). Kaplan-Meier curve for
PVL development showed that there was no difference
in PVL development irrespective of preoperative IST use
(HR 1.27, 95% CI 0.2–5.45, p = 0.752) (Additional file 1:
Figure S3). Kaplan-Meier curves for PVL development
stratified by concomitant ARR and postoperative IST
and are illustrated in Fig. 4. Patients who did not
undergo postoperative IST or concomitant ARR showed
a significantly higher incidence of PVL.
CAVB complicated in BD-related AR
CAVB requiring permanent pacemaker implantation de-
veloped in 17 patients (48.6%). All patients underwent
permanent pacemaker implantation, except 2 patients:
one died of cardiac arrest before pacemaker implant-
ation, and the other refused the procedure. Among the
17 patients requiring pacemaker implantation for CAVB,
information on the AV cusp involved on the first pre-
operative echocardiography and/or the first surgical rec-
ord could be obtained in 11 patients. Non-coronary cusp
of AV was involved in 9 of 11 patients (81.8%).
Discussion
The major findings of this study are summarized as fol-
lows: 1) The prevalence of severe BD-related AR is ap-
proximately 3.1% in all patients with severe AR of
diverse etiologies requiring AV surgery. 2) The rate of
complications such as PVL requiring repeat OHS,
atrioventricular conduction disturbance, and death was
not low. 3) Since the clinical introduction of pathogno-
monic echocardiographic findings suggesting severe
BD-related AR, the incidence rate of PVL, the number
of required repeated OHSs, and cardiac mortality tended
to decrease. 4) BD-related PVL developed more fre-
quently in patients not meeting the conventional ISG
criteria. 5) Finally, concomitant ARR and postoperative
IST were two independent predictors for less PVL devel-
opment, whereas preoperative IST was not.
AR is a rare complication of BD [2–4, 8, 12, 17],
and its pathophysiology has yet to be completely
understood [17]. Although annular dilation and sinus
of Valsalva pseudoaneurysm formation secondary to
aortitis had been suggested [18], direct valvular in-
flammation was also proposed as a critical mechanism
causing AR [2, 12]. Valvular inflammation could lead
to aneurysmal changes in the AV cusp, pseudoaneur-
ysm of aortic root, and mass-like lesions, all of which
are currently considered pathognomonic echocardio-
graphic findings of AR in BD (Additional files 2, 3
and 4: Video S1 S2 and S3) [3–5, 12].
Pathophysiology of recurrent PVL after corrective AV
surgery is not completely understood in this population,
although defective tissue-healing process due to inflam-
mation was suggested as a main pathophysiology [19].
The frequency of early PVL after the first surgery in pa-
tients with BD-related AR was significantly higher (18 of
35 patients, 51.4%), compared to the rate of 2-year PVL
(4 of 404 patients, 1.0%) reported in a previous study,
where patients diagnosed with infective endocarditis
who underwent AVR were included [20]. Thus, it is es-
sential to find the appropriate management strategy (i.e.,
early diagnosis and appropriate perioperative treatment)
to improve postoperative outcome. However, data has
been insufficient, possibly owing to the rarity of the dis-
ease and difficulties in the diagnosis of BD-related AR
prior to full-blown presentation of the ISG criteria.
Because BD has no pathognomonic single diagnostic
test, ISG criteria have been used since 1990 [14]. Not-
withstanding, there were multiple reports showing that
Table 2 Cox proportional hazard regression model for predicting paravalvular leakage development in 76 aortic valve surgeries
Univariable analysis Multivariable analysis
HR 95% CI P value HR 95% CI P value
Age at the time of surgery (years) 0.98 0.95–1.01 0.147 1.01 0.98–1.05 0.463
Female sex 0.13 0.02–0.91 0.040 0.09 0.01–0.79 0.030
ESR (mm/hr) 1.00 0.98–1.02 0.905
Number of OHS performed 0.79 0.47–1.34 0.381
Use of preoperative IST 0.40 0.17–0.95 0.038
Use of postoperative IST 0.23 0.10–0.53 < 0.001 0.38 0.17–0.89 0.025
Concomitant ARR 0.13 0.05–0.33 < 0.001 0.17 0.08–0.36 < 0.001
HR Hazard ratio, CI confidence interval, ESR erythrocyte sediment rate, OHS open heart surgery, IST immunosuppressive therapy, ARR aortic root replacement
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the ISG criteria were not useful for the early diagnosis of
BD-related AR [3, 4, 8, 11–13]. Consistent with earlier
reports, we also observed that only 6 patients (17.1%)
fulfilled the ISG criteria prior to the first AV surgery.
Given poor sensitivity of the ISG criteria in diagnosing
BD-related AR [3, 4, 7, 8, 11–13], diagnosis and treat-
ment may be delayed, leading to poor prognosis. The ab-
sence of vascular manifestations in the ISG criteria may
be one reason why the ISG criteria are considered less
sensitive for the diagnosis of BD-related AR. Besides, the
ISG criteria were originally suggested to elicit common
consent for the diagnosis of BD [14]; thus, it is not suit-
able for the early detection of rare manifestations of BD
on an individual basis. The ICBD introduced vascular
and neurologic manifestations as additional criteria for
the diagnosis of BD [16], and the application of this cri-
teria in our study population could allow the diagnosis
of BD in up to 26 patients (74.3%). Nevertheless, nine
patients in our series were still not put on the diagnostic
list of BD. Thus, we need to keep in mind that severe
AR can be an initial manifestation of BD even in patients
who do not meet the current diagnostic criteria. As the
initial transthoracic echocardiography in all patients in-
variably showed pathognomonic findings reported in the
literature [3–5, 8, 10], we believe that transthoracic
echocardiography can play a critical role in the early
diagnosis of BD-related AR, even in patients who do not
meet the ISG or ICBD criteria [3, 4, 8], and should be
used clinically as a single specific diagnostic test for the
early diagnosis of BD-related AR. We also observed that
patients who did not definitely meet the ISG criteria had
a poorer 2-year PVL-free survival rate, whereas the def-
inite BD group carried better prognosis. This may be re-
lated to the early establishment of IST, which was
confirmed by the multivariate analysis in the current
study. In fact, we observed that postoperative IST, but
not preoperative IST, emerged as an independent factor
preventing PVL development after multivariate analysis.
Besides, as preoperative IST was used in almost every
case in which postoperative IST was used, the direct
comparison of efficacy between preoperative and postop-
erative IST was not fair. To avoid this statistical fallacy,
we performed the sensitivity analysis (Additional file 1:
Figure S3) and confirmed that postoperative IST is an
independent predictor along with concomitant ARR.
This observation can give comfort to cardiologists or
rheumatologists who need to decide whether to proceed
with AV surgery, because most patients with BD-related
severe AR can present with acute heart failure and re-
quire urgent surgery without effective control of
systemic inflammation. Therefore, it may not be accept-
able to delay corrective AV surgery in patients with
BD-related severe AR to control for aortitis or valvulitis.
We should also remember the importance of concomi-
tant ARR as an effective surgical option to decrease PVL
in this population. As the pathergy test implies, exagger-
ated inflammatory response to the injury to the un-
healthy aorta can be elicited in patients with active BD
[19, 21]. Thus, suturing artificial prosthesis such as
mechanical or bioprosthetic valve to the inflamed aortic
root could lead to unsuccessful healing, resulting in early
PVL due to dehiscence. Concomitant ARR at the time of
B
ARR 43 40 37 37 34 34 33 32 31




43 41 38 37 34 33 31 29 28
Postoperat
ive IST (-)







Log rank p<0.0001 Log rank p=0.0001
Fig. 4 Kaplan-Meier estimates of freedom from paravalvular leakage (PVL) stratified by (a) aortic root replacement (ARR) and (b) postoperative
immunosuppressive therapy (IST). The incidence of PVL was significantly higher in patients who did not undergo postoperative IST or concomitant ARR
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AVR using premade valved conduits or homografts can
be the best option to avoid prosthetic valve dehiscence.
CAVB is a well-known complication of BD-related AR.
We found that its incidence was 48.6%, whereas the inci-
dence of CAVB requiring pacemaker implantation after
general AR surgery was reported to be 3.2% [22]. Be-
cause the atrioventricular node is located just below
non-coronary cusp of AV [23], the inflammation of aor-
tic root, esp. non-coronary cusp of AV, and its expansion
to the neighboring atrioventricular node can be a poten-
tial explanation regarding high frequency of CAVB. This
explanation is advocated by the observation that the
non-coronary cusp of AV was involved in 9 of 11 pa-
tients (81.8%) in our series. In addition, development of
interventricular septal dissection (Additional file 3:
Video S2 and Additional file 4: Video S3) mechanically
blocks the atrioventricular node conduction, resulting in
CAVB.
In the past, less attention was paid to BD-related AR,
mainly because of its rarity and absence of pathogno-
monic imaging findings. Since the introduction of char-
acteristic echocardiographic findings [3–5, 8, 10], early
diagnosis and early intervention have been possible,
which is expected to have a favorable impact on out-
comes. This is an important issue but is difficult to
prove, because severe BD-related AR is a rare disease,
and thus, a prospective study is extremely difficult to
perform. Instead, we attempted to investigate the tem-
poral trends of the incidence of PVL, number of re-
quired OHSs, and cardiac mortality by dividing the
study population into three groups according to the time
point when the first surgery was conducted. The de-
creasing trend of adverse events are shown in Fig. 3 sug-
gesting that early detection and appropriate medical and
surgical treatment should improve clinical outcomes.
Several limitations should be acknowledged. Firstly,
only 35 patients with BD-related severe AR were found
and analyzed, making the study susceptible to low statis-
tical power and overfitting issue. However, BD-related
AR is rare in prevalence, and to our knowledge, the
present study included the largest population of patients
with BD-related severe AR requiring AV surgery. Al-
though we included 15 patients who were included in
the previous study [4], the analysis of our study was
completely different from the previous one. Secondly,
nine patients in this study failed to fulfill the current
ISG or ICBD criteria for a definite diagnosis of BD;
hence, there might be an argument regarding the diag-
nostic accuracy in these patients. However, surgical and
pathological findings for all patients showed characteris-
tic histopathology suggesting AV involvement in BD,
and thus, all relevant experts finally agreed on the diag-
nosis of BD. Thirdly, the institutions at which the study
performed were tertiary referral centers, therefore the
prevalence of the BD-related severe AR requiring AVR
could be overestimated. Finally, we initially searched for
patients with severe AR who underwent AV surgery;
therefore, seriously ill patients who could not proceed
with surgical intervention might not have been included
in this study, leaving the possibility of underestimation
of the prevalence of BD-related severe AR.
Conclusions
In conclusion, BD-related severe AR requiring AV sur-
gery is a rare but clinically important disease entity.
Postoperative IST and concomitant ARR, but not pre-
operative IST, are independent predictors of less PVL
development. A special attention is required to early
diagnose BD-related AR, especially in patients who did
not satisfy the ISG criteria. The active use of pathogno-
monic echocardiographic findings could facilitate early
diagnosis.
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